We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+4.34%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+409.32%
AUM
$376B
AUM Growth
+$22.5B
Cap. Flow
+$9.39B
Cap. Flow %
2.5%
Top 10 Hldgs %
15.22%
Holding
6,974
New
204
Increased
3,048
Reduced
3,002
Closed
164

Sector Composition

Rank Sector Weight
1 Technology 14.25%
2 Healthcare 9.45%
3 Financials 9.23%
4 Consumer Discretionary 7.66%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAVE icon
6276
RAVE Restaurant Group
RAVE
$44.8M
$2K ﹤0.01%
500
RCMT icon
6277
RCM Technologies
RCMT
$200M
$2K ﹤0.01%
398
+155
+64% +$571
RVP icon
6278
Retractable Technologies
RVP
$19.8M
$2K ﹤0.01%
2,500
SLNO
6279
DELISTED
Soleno Therapeutics
SLNO
$2K ﹤0.01%
37
-19
-34% -$657
DCOY
6280
Decoy Therapeutics
DCOY
$2.19M
0
SNOA icon
6281
Sonoma Pharmaceuticals
SNOA
$5.26M
$2K ﹤0.01%
13
TBX icon
6282
ProShares Short 7-10 Year Treasury
TBX
$15.9M
$2K ﹤0.01%
+83
New +$2.29K
UTSI icon
6283
UTStarcom
UTSI
$23.5M
$2K ﹤0.01%
125
VANI icon
6284
Vivani Medical
VANI
$112M
$2K ﹤0.01%
112
+13
+13% +$267
ZKIN icon
6285
ZK International Group
ZKIN
$72.8M
$2K ﹤0.01%
196
+53
+37% +$575
TRAW icon
6286
Traws Pharma
TRAW
$6.92M
$2K ﹤0.01%
2
QXO
6287
QXO Inc
QXO
$13.7B
$2K ﹤0.01%
84
IRD
6288
Opus Genetics
IRD
$310M
$2K ﹤0.01%
66
+30
+83% +$678
AUMN
6289
DELISTED
Golden Minerals Company
AUMN
$2K ﹤0.01%
329
-20
-6% -$134
BIMI
6290
DELISTED
BIMI International Medical Inc. Common Stock
BIMI
$2K ﹤0.01%
20
-1,350
-99% -$245K
SDPI
6291
DELISTED
Superior Drilling Products Inc.
SDPI
$2K ﹤0.01%
2,330
+277
+13% +$298
YTEN
6292
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$2K ﹤0.01%
+3
New +$2.87K
ORTX
6293
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$2K ﹤0.01%
15
-166
-92% -$29.1K
MSVB
6294
DELISTED
Mid-Southern Bancorp, Inc.
MSVB
$2K ﹤0.01%
144
+118
+454% +$1.49K
SEAC
6295
DELISTED
Seachange International Inc
SEAC
$2K ﹤0.01%
66
-84
-56% -$2.24K
PLXP
6296
DELISTED
PLx Pharma Inc. Common Stock
PLXP
$2K ﹤0.01%
288
+38
+15% +$206
SIOX
6297
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$2K ﹤0.01%
349
-27,038
-99% -$206K
MMX
6298
DELISTED
Maverix Metals Inc. Common Shares
MMX
$2K ﹤0.01%
+400
New +$1.76K
SMIT
6299
DELISTED
Schmitt Industries Inc
SMIT
$2K ﹤0.01%
1,000
EVFM
6300
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$2K ﹤0.01%
26
+1
+4% +$77

Similar funds

Morgan Stanley's Q2 2019 Portfolio in Review

As of Q2 2019, Morgan Stanley held 6,974 positions worth $376B, up 6.4% from $353B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Morgan Stanley's Q2 2019 filing shows 204 new, 3,048 increased, 3,002 reduced and 164 closed positions. Its largest new stake was Uber: 20,700,032 shares worth $960M. The largest sale was Starbucks, an estimated $610M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

  • Morgan Stanley's largest Q2 2019 buy was Uber: 20,700,032 shares worth $960M.
  • Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q2 2019, an estimated $2.28B increase.
  • Morgan Stanley's biggest Q2 2019 reduction was Starbucks, cutting an estimated $610M.
  • Morgan Stanley fully exited Churchill Capital Corp in Q2 2019, selling an estimated $70.9M.
  • Morgan Stanley's ten largest holdings make up 15% of its $376B portfolio in Q2 2019.
  • Morgan Stanley opened 204 new positions and closed 164 in Q2 2019.
  • Morgan Stanley's portfolio value rose 6.4% quarter-over-quarter to $376B.

Based on Morgan Stanley's 13F filing for Q2 2019, filed 14 Aug 2019.